The overall objectives are to demonstrate at least in one disease (diabetes), that stem cell-based cell replacement therapy is effective and safe, to provide therapeutic candidates for stroke and hematological diseases, and to build a strong base of knowledge about stem cells and disease mechanisms to pave the way for future efforts to devise new clinically effective treatments.
2011-10-04
StemTherapy Scientific Advisory Board visited Lund 10-11 November. During the visit StemTherapy organised the symposium Cutting edge stem cell research.
2011-06-20
Doctoral grant in biomedicine - neurology/stem cell therapy (PI Zaal Kokaia) OBS! Application period has expired!
2011-06-20
Professor Zaal Kokaia and Associate Professor David Bryder from Lund Stem Cell Center, members of the Stem Therapy program, received 6 and 5 million SEK, respectively for their projects in the field of stem cell-based regenerative medicine.
Page Manager: Katarina Branzén
Last modified: 2012-02-01
Associate PI´s:
